We are thrilled to share groundbreaking news—BioRePeelCl3® FND and BODY has officially attained EU MDR certification, becoming the first-ever peeling in the aesthetic industry to obtain the indispensable CE mark under these stringent standards.
This landmark achievement underscores CMed Aesthetics’ unwavering dedication to quality, safety and innovation in aesthetic medicine. Meeting the rigorous EU MDR requirements reflects the exceptional standards of BioRePeelCl3® and its alignment with the highest European safety and efficacy benchmarks.
The EU MDR (Medical Device Regulation) certification not only highlights our commitment to delivering safe and effective products but also places BioRePeelCl3® FND and BODY in a class of its own as a trusted solution for aesthetic professionals worldwide.
We extend our heartfelt gratitude to all the partners, distributors and practitioners who have supported us on this journey. Your trust and collaboration continue to inspire us to push boundaries and redefine standards in aesthetic medicine.
Discover more about BioRePeelCl3 and BioReTherapy here.
